Nicholas I. Simon

1.2k total citations
31 papers, 720 citations indexed

About

Nicholas I. Simon is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Nicholas I. Simon has authored 31 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Nicholas I. Simon's work include Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Genomics and Diagnostics (6 papers). Nicholas I. Simon is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Genomics and Diagnostics (6 papers). Nicholas I. Simon collaborates with scholars based in United States, United Kingdom and China. Nicholas I. Simon's co-authors include Steven P. Balk, Changmeng Cai, Sen Chen, Hongyun Wang, Shaoyong Chen, Peter S. Nelson, Brett T. Marck, Alvin M. Matsumoto, Glenn J. Bubley and Patrick Kwok‐Shing Ng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Nicholas I. Simon

26 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas I. Simon United States	11	521	253	240	178	154	31	720
Yusuke Imamura Japan	15	399 0.8×	169 0.7×	315 1.3×	98 0.6×	154 1.0×	77	765
Mary Barrett United Kingdom	4	589 1.1×	226 0.9×	327 1.4×	275 1.5×	181 1.2×	7	923
Barur Rajeshkumar United States	7	696 1.3×	225 0.9×	349 1.5×	305 1.7×	93 0.6×	11	923
Alison Reid United Kingdom	13	746 1.4×	400 1.6×	412 1.7×	98 0.6×	306 2.0×	20	1.1k
Stephen Balk United States	6	720 1.4×	436 1.7×	458 1.9×	295 1.7×	104 0.7×	8	1.0k
Julia Shelkey United States	6	821 1.6×	303 1.2×	239 1.0×	194 1.1×	190 1.2×	9	956
Emilda Thompson United Kingdom	4	658 1.3×	223 0.9×	178 0.7×	292 1.6×	147 1.0×	7	766
Mari Nakazawa United States	10	836 1.6×	434 1.7×	334 1.4×	149 0.8×	265 1.7×	25	1.0k
Nikhil Babu Oommen United Kingdom	6	904 1.7×	366 1.4×	255 1.1×	383 2.2×	220 1.4×	7	1.1k
S. Settatree United Kingdom	5	572 1.1×	194 0.8×	170 0.7×	271 1.5×	111 0.7×	10	702

Countries citing papers authored by Nicholas I. Simon

Since Specialization

Citations

This map shows the geographic impact of Nicholas I. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas I. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas I. Simon more than expected).

Fields of papers citing papers by Nicholas I. Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas I. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas I. Simon. The network helps show where Nicholas I. Simon may publish in the future.

Co-authorship network of co-authors of Nicholas I. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas I. Simon. A scholar is included among the top collaborators of Nicholas I. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas I. Simon. Nicholas I. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, Nicholas I., Stephanie Berg, Alan Tan, et al.. (2025). Preferred treatment regimens for rare genitourinary (GU) malignancies.. Journal of Clinical Oncology. 43(5_suppl). 780–780.

Apolo, Andrea B., et al.. (2025). Top advances of the year: Bladder cancer. Cancer. 131(16). e70020–e70020. 1 indexed citations

Simon, Nicholas I., Daniel M. Girardi, Lisa Ley, et al.. (2025). A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)—design and rationale. Future Oncology. 21(10). 1171–1177.

Simon, Nicholas I., Daniel M. Girardi, Lisa Ley, et al.. (2025). E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors—design and rationale. Future Oncology. 21(13). 1625–1630. 1 indexed citations

Simon, Nicholas I., Daniel M. Girardi, Lisa Ley, et al.. (2024). A phase II multicenter study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors (E-VIRTUE).. Journal of Clinical Oncology. 42(16_suppl). TPS4628–TPS4628.

Simon, Nicholas I., Scot A. Niglio, Lisa Ley, et al.. (2024). A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (LASER).. Journal of Clinical Oncology. 42(16_suppl). TPS4629–TPS4629. 1 indexed citations

Iannantuono, Giovanni Maria, Ninet Sinaii, Nicholas I. Simon, et al.. (2024). Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 3(1). e000335–e000335. 12 indexed citations

Apolo, Andrea B., Christine Michaels-Igbokwe, Nicholas I. Simon, et al.. (2024). Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding. Patient. 18(1). 77–87. 3 indexed citations

Simon, Nicholas I., Lisa M. Cordes, Elizabeth Smith, et al.. (2024). SMART: A phase II study of sacituzumab govitecan (SG) with or without atezolizumab immunotherapy in rare genitourinary (GU) tumors such as small cell, adenocarcinoma, and squamous cell bladder/urinary tract cancer, renal medullary carcinoma (RMC) and penile cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS4627–TPS4627. 3 indexed citations

10.

Simon, Nicholas I., Scot A. Niglio, Giovanni Maria Iannantuono, et al.. (2023). A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies.. Journal of Clinical Oncology. 41(16_suppl). 4571–4571. 1 indexed citations

11.

Apolo, Andrea B., Nicholas I. Simon, Simrun Grewal, et al.. (2023). Understanding drivers of treatment preferences in locally advanced or metastatic urothelial carcinoma: A qualitative interview study with patients, caregivers, and physicians.. Journal of Clinical Oncology. 41(6_suppl). 492–492. 3 indexed citations

12.

Simon, Nicholas I., et al.. (2021). Disaggregating Data on Pacific Islander Gastric Cancer Patients Reveals Survival Disparity. Journal of Gastrointestinal Cancer. 53(1). 144–150. 4 indexed citations

13.

Stewart, Tyler F., Nikhil V. Kotha, Hannah Dzimitrowicz, et al.. (2021). Efficacy of anti-PD(L)1 therapy for patients (Pts) with advanced urothelial carcinoma (aUC) with primary resistance to platinum-based chemotherapy (PC).. Journal of Clinical Oncology. 39(15_suppl). e16515–e16515.

14.

Chae, Young Kwang, Andrew A. Davis, Lee Chun Park, et al.. (2020). Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy. Translational Lung Cancer Research. 9(4). 1015–1028. 15 indexed citations

15.

Simon, Nicholas I., Young Kwang Chae, Nisha Mohindra, & Victoria Villaflor. (2019). P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment. Journal of Thoracic Oncology. 14(10). S623–S624. 1 indexed citations

16.

Chae, Young Kwang, Andrew A. Davis, Sarita Agte, et al.. (2019). Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer. The Oncologist. 24(6). 820–828. 76 indexed citations

17.

Chen, Sen, Changmeng Cai, Adam G. Sowalsky, et al.. (2018). BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer. Cancer Research. 78(18). 5203–5215. 21 indexed citations

18.

Davis, Andrew A., Young Kwang Chae, Sarita Agte, et al.. (2017). Comparison of tumor mutational burden (TMB) across tumor tissue and circulating tumor DNA (ctDNA).. Journal of Clinical Oncology. 35(15_suppl). e23028–e23028. 23 indexed citations

19.

Chen, Sen, Xinnong Jiang, Christina Gewinner, et al.. (2013). Tyrosine Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating the Activation of Multiple Receptor Tyrosine Kinases. Science Signaling. 6(277). ra40–ra40. 18 indexed citations

20.

Cai, Changmeng, Sen Chen, Patrick Kwok‐Shing Ng, et al.. (2011). Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors. Cancer Research. 71(20). 6503–6513. 349 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact